Balyasny Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.6M | Buy |
115,275
+102,159
| +779% | +$33.3M | 0.06% | 334 |
|
|
2025
Q1 | $3.54M | Buy |
+13,116
| New | +$3.54M | 0.01% | 965 |
|
|
2024
Q4 | – | Sell |
-33,405
| Closed | -$9.19M | – | 1893 |
|
|
2024
Q3 | $9.19M | Buy |
+33,405
| New | +$9.19M | 0.02% | 701 |
|
|
2024
Q2 | – | Sell |
-287,627
| Closed | -$43M | – | 1892 |
|
|
2024
Q1 | $43M | Buy |
+287,627
| New | +$43M | 0.08% | 273 |
|
|
2023
Q2 | – | Sell |
-251,798
| Closed | -$50.4M | – | 1831 |
|
|
2023
Q1 | $50.4M | Buy |
251,798
+251,279
| +48,416% | +$50.3M | 0.13% | 169 |
|
|
2022
Q4 | $123K | Sell |
519
-47,259
| -99% | -$11.2M | ﹤0.01% | 1780 |
|
|
2022
Q3 | $9.56M | Sell |
47,778
-15,732
| -25% | -$3.15M | 0.03% | 565 |
|
|
2022
Q2 | $9.26M | Buy |
+63,510
| New | +$9.26M | 0.03% | 560 |
|
|
2022
Q1 | – | Sell |
-81,241
| Closed | -$13.8M | – | 2088 |
|
|
2021
Q4 | $13.8M | Buy |
81,241
+41,097
| +102% | +$6.97M | 0.05% | 454 |
|
|
2021
Q3 | $7.58M | Buy |
40,144
+16,652
| +71% | +$3.14M | 0.03% | 566 |
|
|
2021
Q2 | $3.98M | Sell |
23,492
-99,707
| -81% | -$16.9M | 0.02% | 694 |
|
|
2021
Q1 | $17.4M | Buy |
123,199
+118,699
| +2,638% | +$16.8M | 0.09% | 272 |
|
|
2020
Q4 | $585K | Sell |
4,500
-53,774
| -92% | -$6.99M | ﹤0.01% | 951 |
|
|
2020
Q3 | $8.49M | Buy |
+58,274
| New | +$8.49M | 0.06% | 374 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 930 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 999 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1024 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1009 |
|
|
2018
Q4 | – | Sell |
-10,046
| Closed | -$879K | – | 1254 |
|
|
2018
Q3 | $879K | Sell |
10,046
-235,670
| -96% | -$20.6M | ﹤0.01% | 1000 |
|
|
2018
Q2 | $24.2M | Buy |
+245,716
| New | +$24.2M | 0.11% | 232 |
|
|
2018
Q1 | – | Sell |
-7,676
| Closed | -$975K | – | 1709 |
|
|
2017
Q4 | $975K | Buy |
+7,676
| New | +$975K | ﹤0.01% | 1104 |
|
|
2017
Q3 | – | Sell |
-8,861
| Closed | -$707K | – | 1638 |
|
|
2017
Q2 | $707K | Sell |
8,861
-194,606
| -96% | -$15.5M | ﹤0.01% | 987 |
|
|
2017
Q1 | $10.4M | Sell |
203,467
-139,355
| -41% | -$7.14M | 0.05% | 419 |
|
|
2016
Q4 | $12.8M | Buy |
+342,822
| New | +$12.8M | 0.07% | 335 |
|
|
2016
Q2 | – | Sell |
-55,671
| Closed | -$3.49M | – | 964 |
|
|
2016
Q1 | $3.49M | Buy |
+55,671
| New | +$3.49M | 0.02% | 470 |
|
|
2015
Q3 | – | Sell |
-2,325
| Closed | -$279K | – | 960 |
|
|
2015
Q2 | $279K | Buy |
+2,325
| New | +$279K | ﹤0.01% | 731 |
|